Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report

Na, Zhi; Mo, Qian; Yang, Shuo; Qin, Yuan-xing; Chen, Hao; Wu, Zengguang; Lan, Cai-hong; Zhang, Jun; Li, Yin-long

doi:10.1016/j.joim.2020.11.005

Cited by 10 publications

(10 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…COVID-19 is a worldwide pandemic that has proliferated across the globe since its spread from Wuhan, China, in December 2019 [1][2][3]. Since then, full clinical presentations of this viral infection are still not fully understood, as being an RNA virus with many variants, its clinical manifestations are always different [4].…”

Section: Introductionmentioning

confidence: 99%

Presenting Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in Pakistan: Retrospective Observational Study

Akhtar¹,

Khalid²,

Rahman³

et al. 2021

JMIR Public Health Surveill

View full text Add to dashboard Cite

Background COVID-19 became a pandemic rapidly after its emergence in December 2019. It belongs to the coronavirus family of viruses, which have struck a few times before in history. Data based on previous research regarding etiology and epidemiology of other viruses from this family helped played a vital role in formulating prevention and precaution strategies during the initial stages of this pandemic. Data related to COVID-19 in Pakistan were not initially documented on a large scale. In addition, due to a weak health care system and low economic conditions, Pakistan’s population, in general, already suffers from many comorbidities, which can severely affect the outcome of patients infected with COVID-19. Objective COVID-19 infections are coupled with a manifestation of various notable outcomes that can be documented and characterized clinically. The aim of this study was to examine these clinical manifestations, which can serve as indicators for early detection as well as severity prognosis for COVID-19 infections, especially in high-risk groups. Methods A retrospective observational study involving abstraction of demographic features, presenting symptoms, and adverse clinical outcomes for 1812 patients with COVID-19 was conducted. Patients were admitted to the four major hospitals in the Rawalpindi-Islamabad region of Pakistan, and the study was conducted from February to August 2020. Multivariate regression analysis was carried out to identify significant indicators of COVID-19 severity, intensive care unit (ICU) admission, ventilator aid, and mortality. The study not only relates COVID-19 infection with comorbidities, but also examines other related factors, such as age and gender. Results This study identified fever (1592/1812, 87.9%), cough (1433/1812, 79.1%), and shortness of breath (998/1812, 55.1%) at the time of hospital admission as the most prevalent symptoms for patients with COVID-19. These symptoms were common but not conclusive of the outcome of infection. Out of 1812 patients, 24.4% (n=443) required ICU admission and 21.5% (n=390) required ventilator aid at some point of disease progression during their stay at the hospital; 25.9% (n=469) of the patients died. Further analysis revealed the relationship of the presented symptoms and comorbidities with the progression of disease severity in these patients. Older adult patients with comorbidities, such as hypertension, diabetes, chronic kidney disease, and asthma, were significantly affected in higher proportions, resulting in requirement of ICU admission and ventilator aid in some cases and, in many cases, even mortality. Conclusions Older adult patients with comorbidities, such as hypertension, diabetes, asthma, chronic obstructive pulmonary disorder, and chronic kidney disease, are at increased risk of developing severe COVID-19 infections, with an increased likelihood of adverse clinical outcomes.

show abstract

Section: Introductionmentioning

confidence: 99%

Presenting Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in Pakistan: Retrospective Observational Study

Akhtar¹,

Khalid²,

Rahman³

et al. 2021

JMIR Public Health Surveill

View full text Add to dashboard Cite

show abstract

“…Various symptoms were targeted in one publication ( Table 1 ) [ 26 ]. Among the two clinical studies, one was a prospective case-control study [ 10 ], and the other was a single case report [ 11 ]; both assessed the clinical effects of Chinese herbal medicine (CHM) decoctions for lung inflammation. In these two studies, CHM was reported to be effective in relieving symptoms of pulmonary dysfunction in patients after COVID-19 infection [ 10 , 11 ].…”

Section: Resultsmentioning

confidence: 99%

Complementary and Alternative Medicine for Long COVID: Scoping Review and Bibliometric Analysis

Kim

Jeon

Kang

et al. 2022

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Prolonged symptoms after the clearance of acute coronavirus disease 2019 (COVID-19) infection, termed long COVID, are an emerging threat to the post-COVID-19 era. Complementary and alternative medicine (CAM) interventions may play a significant role in the management of long COVID. The present study aimed to identify published studies on the use of CAM interventions for long COVID and provide an overview of the research status using bibliometric analysis. The present scoping review searched MEDLINE, Embase, and Cochrane Library from inception until November 2021 and identified published studies on CAM interventions for long COVID. A narrative analysis of the study types and effectiveness and safety of the CAM interventions are presented and a bibliometric analysis of citation information and references of the included publications were analyzed using the Bibliometrix package for R. An electronic database search identified 16 publications (2 clinical studies and 14 study protocols of systematic reviews or clinical studies) that were included in the present study. Dyspnea or pulmonary dysfunction, quality of life, olfactory dysfunction, and psychological symptoms after COVID-19 infection were assessed in the included publications. The two clinical studies suggested that Chinese herbal medications were effective in relieving symptoms of pulmonary dysfunction. Bibliometric analysis revealed the current trend of research publication in this area was driven by study protocols written by Chinese, Korean, and Indian authors. Thus, the present scoping review and bibliometric analysis revealed that there are few studies published about the use of CAM for long COVID and long-term management for COVID-19 survivors. Original studies on CAM interventions, including randomized controlled trials and systematic reviews, are required to actively support evidence for their use in the management of long COVID. PROSPERO registration: this trial is registered with CRD42021281526.

show abstract

“…A meta-analysis by Wang et al [22] showed that the Lianhua Qingwen Capsule can significantly improve the effect of Western medicine in alleviating COVID-19 symptoms. Also, the consumption of Chinese herbal medicine as a co-therapy with acupuncture [23] , [24] was shown to be beneficial to COVID-19 treatment.…”

Section: Using Clinical Data To Verify the Effectiveness Of Cam Treatments For Covid-19mentioning

confidence: 99%

Complementary and alternative medicine during COVID-19 pandemic: What we have done

Ling¹

2022

Journal of Integrative Medicine

View full text Add to dashboard Cite

Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report

Cited by 10 publications

References 5 publications

Presenting Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in Pakistan: Retrospective Observational Study

Presenting Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in Pakistan: Retrospective Observational Study

Complementary and Alternative Medicine for Long COVID: Scoping Review and Bibliometric Analysis

Complementary and alternative medicine during COVID-19 pandemic: What we have done

Contact Info

Product

Resources

About